Answer
Sotorasib specifically targets KRAS G12C. A validated tumour test must confirm this mutation because cancers without it are not covered by the licensed indication.
Sources for this answer
- LUMYKRAS 240 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.